Research Article
Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study
Table 7
Cumulative recurrent PAF* at the end of follow-up in the second investigation.
| Groups (case number) |
Male |
Female | Total number | Cumulative recurrent PAF | Total number | Cumulative recurrent PAF |
| WK* treatment (54 cases) | 27 | 0 | 27 | 1 | Sotalol treatment (54 cases) | 27 | 2 | 27 | 0 | Control (55 cases) | 35 | 4 | 20 | 5 |
| value ( value | 6.886 (0.009) | value ( value | 4.813 (0.028) | value ( value | 0.343 (0.558) |
|
|
WK: Wenxin Keli; PAF: paroxysmal atrial fibrillation; **analyzed by test.
|